← FDA DRUG APPROVALS

FDA ANDA · ANDA072300

IBUPROFEN

Sponsor: CONTRACT PHARMACAL

APPLICATION
ANDA072300
TYPE
ANDA
ORIGINAL APPROVAL
1988-07-01
LATEST ACTION
2016-05-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

IBUPROFENPrescription
IBUPROFEN 800MG · TABLET · ORAL

Approval history

2016-05-09Labeling · Supplement 2 · standardAP
1989-01-23Labeling · Supplement 1AP
1988-07-01OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →